Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Age Considerations Age is a significant factor, particularly for peptides that interact with the Growth Hormone axis
GLP-1 serves as both a peptide hormone and a growth factor, is released upon nutrient intake, and promotes insulin secretion stimulated by glucose levels
Clinical evidence shows this combination produces measurable increases in growth hormone and IGF-1, the markers your provider tracks to confirm the protocol is working
While Mounjaros clinical results are promising, differentiation versus Ozempic is not clean cut, as clinical results appear to be dose dependent, and Ozempic may have a slight advantage in terms of gastrointestinal (GI) tolerability and dropout rates (discontinuation rates due to adverse events in tirzepatide arms were 5.1% 7.9% compared to 3.8% in semaglutide cohort)
With breakthroughs in oral small-molecule GLP-1 drugs, the global metabolic treatment market is entering a new phase of competition
